Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > AKLI Akili > Detailed Quotes

AKLI Akili

Watchlist
1.610
+0.030+1.90%
Trading Session  02/01 15:14 ET
High
1.630
Open
1.630
Turnover
46.96K
Low
1.570
Pre Close
1.580
Volume
29.59K
Market Cap
125.43M
P/E(TTM)
Loss
52wk High
37.581
Shares
77.91M
P/E(Static)
Loss
52wk Low
0.855
Float Cap
59.51M
Bid/Ask %
97.92%
Historical High
37.581
Shs Float
36.97M
Volume Ratio
0.54
Historical Low
0.855
Dividend TTM
--
Div Yield TTM
--
P/B
1.01
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.08%
Amplitude
3.80%
Avg Price
1.587
Lot Size
1
Float Cap
59.51M
Bid/Ask %
97.92%
Historical High
37.581
Shs Float
36.97M
Volume Ratio
0.54
Historical Low
0.855
Dividend TTM
--
P/B
1.01
Dividend LFY
--
Turnover Ratio
0.08%
Amplitude
3.80%
Avg Price
1.587
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Akili, Inc.(formerly Social Capital Suvretta Holdings Corp. I) , a commercialized company that develops digital therapies that combine science and technology to address cognitive disorders such as patient inattention, memory loss, difficulty learning new skills, and difficulty making decisions, is a new category of software-based medicine. The company has used its approach to technology that targets the brain directly to build a new class of drugs - drugs that have been validated in clinical trials, such as drugs or medical devices. The company's platform is powered by a proprietary therapeutic engine designed to target cognitive disorders in the brain, informed by decades of research and validated by a rigorous clinical program.
CEO: Dr. W. Edward Martucci, PhD
Market: NASDAQ
Listing Date: 06/30/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist